Exposure to hepatitis B virus activates immunity in young people, suggesting benefits for earlier treatment

February 27, 2013
Exposure to hepatitis B virus activates immunity in young people, suggesting benefits for earlier treatment
A computer-generated image of the hepatitis B virus. Credit: iStockphoto/Thinkstock

Infectious disease experts have long thought that children, teenagers and young adults who are chronically infected with the hepatitis B virus (HBV) lack the immune cells needed to fight this pathogen. As such, physicians currently withhold therapeutic interventions from younger patients until they have reached an advanced age—typically around 30 years old—at which time the immune system is thought to have 'awakened' to the virus.

Yet, contrary to the conventional medical wisdom, new research from the A*STAR Singapore Institute for Clinical Sciences (SICS) indicates that there is no such inherent age-associated period of so-called '' to HBV. In fact, older people with chronic hepatitis B seem to have a weaker immune response, represented by weaker antiviral T-cell repertoires, than younger individuals infected with the virus.

"These findings can have major implications for the clinical management of chronic hepatitis B infections," says the SICS's Antonio Bertoletti, who led the research. "It might be better to start treatment early, as young people have a less compromised HBV-, and [because] functional recovery of HBV-specific is associated with successful control of the infection."

Scientists from Bertoletti's laboratory, together with clinical collaborators in the UK, isolated T cells from 44 people with chronic HBV infections between the ages of 10 and 30, the majority of whom were of Asian descent. Around 75% of the world's 400 million people with chronic can be found within the region of Asia.

They compared the immune samples to those from healthy age-matched controls, and showed that young patients infected with HBV expressed increased levels of virus-associated T cells, and these T cells displayed the ability to expand and produce pro-inflammatory signaling molecules known as cytokines, which are involved in antiviral responses. Furthermore, these HBV-specific T cells became more dysfunctional with age, the authors found, suggesting that the longer a patient is left untreated, the less effective the immune system becomes at clearing the virus.

The study upends the idea that immune recognition of HBV is somehow averted in certain individuals, thus indicating that all patients, regardless of age, could be suitable for treatment. It also highlights the inadequacy of measuring biomarkers of liver inflammation—the current proxy for immune activity in people with B infections. Such indicators are typically absent in young patients despite the study's suggestion of the presence of active T-cell responses to the virus.

Explore further: Earlier treatment for young patients with chronic hepatitis B more effective in clearing virus

More information: Kennedy, P. T. F., Sandalova, E., Jo, J., Gill, U., Ushiro-Lumb, I. et al. Preserved T-cell function in children and young adults with immune-tolerant chronic hepatitis B. Gastroenterology 143, 637–645 (2012). dx.doi.org/10.1053/j.gastro.2012.06.009

Related Stories

Earlier treatment for young patients with chronic hepatitis B more effective in clearing virus

September 6, 2012
Scientists from A*STAR's Singapore Institute for Clinical Sciences (SICS), together with clinical collaborators from London , discovered for the first time that children and young patients with chronic Hepatitis B Virus infection ...

Scientists shed light on mystery surrounding hepatitis B virus: Discovery is decades in the making

January 9, 2013
(Medical Xpress)—Scientists from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), part of the National Institutes of Health, and the University of Oxford, U.K., have shed light on a long-standing ...

Recommended for you

Scientists develop infection model for tickborne flaviviruses

August 22, 2017
National Institutes of Health (NIH) scientists have filled a research gap by developing a laboratory model to study ticks that transmit flaviviruses, such as Powassan virus. Powassan virus was implicated in the death of a ...

Zika virus stifles pregnant women's weakened immune system to harm baby, study finds

August 21, 2017
The Zika virus, linked to congenital birth defects and miscarriages, suppresses a pregnant woman's immune system, enabling the virus to spread and increasing the chances an unborn baby will be harmed, a Keck School of Medicine ...

Novel approach to track HIV infection

August 18, 2017
Northwestern Medicine scientists have developed a novel method of tracking HIV infection, allowing the behavior of individual virions—infectious particles—to be connected to infectivity.

Faulty gene linked to obesity in adults

August 18, 2017
Groundbreaking new research linking obesity and metabolic dysfunction to a problem in the energy generators in cells has been published by researchers from the Harry Perkins Institute of Medical Research and The University ...

Two lung diseases killed 3.6 million in 2015: study

August 17, 2017
The two most common chronic lung diseases claimed 3.6 million lives worldwide in 2015, according to a tally published Thursday in The Lancet Respiratory Medicine.

New test differentiates between Lyme disease, similar illness

August 16, 2017
Lyme disease is the most commonly reported vector-borne illness in the United States. But it can be confused with similar conditions, including Southern Tick-Associated Rash Illness. A team of researchers led by Colorado ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.